TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Singapore S.E.

T14

CNE100000924

Pharmaceuticals

Market Closed - Singapore S.E. Other stock markets 04:59:56 2024-04-26 am EDT			5-day change	1st Jan Change
2 ^USD	+1.52%		+0.50%	-3.38%

Apr. 02	Tianjin Pharmaceutical Da Ren Tang's 2023 Profit Rises 14.5%	MT
Mar. 29	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited(SGX:T14) dropped from S&P Global BMI Index

September 19, 2022 at 12:00 am EDT

Latest news about Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Tianjin Pharmaceutical Da Ren Tang's 2023 Profit Rises 14.5%	Apr. 02	MT
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Singapore Index Slips into Red on Weak US Data; OCBC Shares Close Flat Following Pricing of Perpetual Capital Securities	Jan. 10	MT
Portion of Tianjin Pharmaceutical Controlling Shareholder's Shares Placed Under Judicial Freeze	Jan. 09	MT
Tianjin Pharmaceutical Taps Affiliate for Brand Promotion	Dec. 20	MT
Tianjin Pharmaceutical Hires Contractor for Renovation of Workshop, Warehouses	Dec. 19	MT
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Board Changes	Dec. 19	CI

Chart Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Duration

Period

Chart Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

More charts

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The Company's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.

Sector

Pharmaceuticals

Calendar

2024-04-29 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

34.37 CNY

Average target price

45.8 CNY

Spread / Average Target

+33.26%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.49B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.06B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.61B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.81B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.66B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.55B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+33.40%	1.41B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+34.29%	1.34B

Alternative Medicine

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Singapore S.E.

Equities

T14

CNE100000924

Pharmaceuticals

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited(SGX:T14) dropped from S&P Global BMI Index

Latest news about Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Chart Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Company Profile

Income Statement Evolution

Ratings for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Alternative Medicine